- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00789347
Analysis of Cortical Excitability in Neuropathic Pain
Analysis of Cortical Excitability in Neuropathic Pain: an Electrophysiology Study.
Study Overview
Status
Conditions
Detailed Description
There are several brain areas responsible for neuropathic pain reported in functional image studies, including primary sensory cortex, insula, and anterior cingulate gyrus. However, it is few informations about the functional status of these areas. Besides, the reason of the individual variability about the developement of neuropathic pain remains unknown. It is lack of satisfactory explanation about why some people developed neuropathic pain in certain diseased situation (for example, type 2 diabetes), while others do not.
We hypothesis that patients with neuropathic pain has abnormal cortical excitability and plasticity in certain brain area. Therefore developed neuropathic pain certain diseased condition while others not. Therefore, we will use multimodal electrophysiology tools,such as transcranial magnetic stimulation, peripheral nerve stimulation, and contact heat evoke potential to monitor the cortical excitability and plasticity non-invasively.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Ming-Kai Pan, M.D.
- Phone Number: 9803397 886-2-23123456
- Email: emorypan@gmail.com
Study Contact Backup
- Name: Ch-Chao Chao, M.D.
- Phone Number: 9801967 886-2-23123456
- Email: ccchao@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Ming-Kai Pan, M.D.
- Phone Number: 9803397 886-2-23123456
- Email: emorypan@gmail.com
-
Contact:
- Chi-Chao Chao, M.D.
- Phone Number: 9801967 886-2-23123456
- Email: ccchao@ntu.edu.tw
-
Sub-Investigator:
- Ming-Kai Pan, M.D.
-
Principal Investigator:
- Sung-Tsang Hsieh, M.D. PhD
-
Sub-Investigator:
- Chi-Chao Chao, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy volunteers
- patients with pain resulted from dysfunction of peripheral or central nervous system
- the disorders of peripheral nerves are diagnosed by nerve conduction study, quantitative sensory test, quantification of skin innervation or contact heat evoked potentials
- lesion of central nervous system should be confirmed by neuroimage.
Exclusion Criteria:
- previous history of epilepsy, seizure disorders or major head injury
- previous brain surgery or intracranial metalic implant
- implanted devices as cardiac pacemaker
- pregnant subjects
- patient with severe cardiac or pulmonary disease who potentially cannot tolerate stress
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
1
Healthy volunteers
|
2
Patient with neuropathic pain
|
3
patients without neuropathic pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Abnormal cortical excitability in motor-sensory cross-talk
Time Frame: non-applicable
|
non-applicable
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Genetic variability of neurotrophic factors between groups
Time Frame: non-applicable
|
non-applicable
|
Collaborators and Investigators
Investigators
- Study Director: Ming-Kai Pan, M.D., National Taiwan University Hospital, Department of Neurology
- Study Director: Chi-Chao Chao, M.D., National Taiwan University Hospital, Department of Neurology
- Principal Investigator: Sung-Tsang Hsieh, M.D. PhD, National Taiwan University Hospital, Department of Neurology
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200806061R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuropathic Pain
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
University Hospital, Clermont-FerrandRecruitingPeripheral Neuropathic PainFrance
-
Daiichi Sankyo Co., Ltd.CompletedCentral Neuropathic PainJapan, Korea, Republic of, Taiwan
-
Hospices Civils de LyonCompletedPharmacoresistant Neuropathic PainFrance
-
Yuhan CorporationCompletedPeripheral Neuropathic PainKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedNeuropathic Pain RebelFrance
-
University Hospital, Strasbourg, FranceTerminatedPostthoracotomy Pain | Postthoracoscopy Neuropathic PainFrance
-
AstraZenecaCompletedNociceptive Pain | Peripheral Neuropathic PainUnited Kingdom
-
Ashwin ViswanathanBoston Scientific CorporationNot yet recruitingChronic Pain | Neuropathic Pain | Pain, NeuropathicUnited States